Literature DB >> 11861866

Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.

Xiao-Qing Zhao1, Xiao-Li Huang, Phalguni Gupta, Luann Borowski, Zheng Fan, Simon C Watkins, Elaine K Thomas, Charles R Rinaldo.   

Abstract

T-cell responses to X4 strains of human immunodeficiency virus type 1 (HIV-1) are considered important in controlling progression of HIV-1 infection. We investigated the ability of dendritic cells (DC) and various forms of HIV-1 X4 antigen to induce anti-HIV-1 T-cell responses in autologous peripheral blood mononuclear cells from HIV-1-infected persons. Immature DC loaded with HIV-1 IIIB-infected, autologous, apoptotic CD8(-) cells and matured with CD40 ligand induced gamma interferon production in autologous CD8(+) and CD4(+) T cells. In contrast, mature DC loaded with HIV-1 IIIB-infected, necrotic cells or directly infected with cell-free HIV-1 IIIB were poorly immunogenic. Thus, HIV-1-infected cells undergoing apoptosis serve as a rich source of X4 antigen for CD8(+) and CD4(+) T cells by DC. This may be an important mechanism of HIV-1 immunogenicity and provides a strategy for immunotherapy of HIV-1-infected patients on combination antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861866      PMCID: PMC135963          DOI: 10.1128/jvi.76.6.3007-3014.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells.

Authors:  J S Kuniyoshi; C J Kuniyoshi; A M Lim; F Y Wang; E R Bade; R Lau; E K Thomas; J S Weber
Journal:  Cell Immunol       Date:  1999-04-10       Impact factor: 4.868

2.  Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function.

Authors:  P Rovere; C Vallinoto; A Bondanza; M C Crosti; M Rescigno; P Ricciardi-Castagnoli; C Rugarli; A A Manfredi
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

Review 3.  Immune control of HIV-1 replication.

Authors:  B D Walker; E S Rosenberg; C M Hay; N Basgoz; O O Yang
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

Review 4.  Mechanisms of MHC class I--restricted antigen processing.

Authors:  E Pamer; P Cresswell
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

5.  Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.

Authors:  J F McDyer; M Dybul; T J Goletz; A L Kinter; E K Thomas; J A Berzofsky; A S Fauci; R A Seder
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

6.  The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage.

Authors:  B Canque; Y Bakri; S Camus; M Yagello; A Benjouad; J C Gluckman
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

7.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.

Authors:  M L Albert; B Sauter; N Bhardwaj
Journal:  Nature       Date:  1998-03-05       Impact factor: 49.962

8.  Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.

Authors:  J N Blankson; J E Gallant; R F Siliciano
Journal:  J Infect Dis       Date:  2001-01-12       Impact factor: 5.226

9.  Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.

Authors:  C R Rinaldo; J M Liebmann; X L Huang; Z Fan; Q Al-Shboul; D K McMahon; R D Day; S A Riddler; J W Mellors
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

10.  Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.

Authors:  M L Albert; S F Pearce; L M Francisco; B Sauter; P Roy; R L Silverstein; N Bhardwaj
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more
  16 in total

1.  Autologous apoptotic T cells interact with dendritic cells, but do not affect their surface phenotype or their ability to induce recall immune responses.

Authors:  P J Newton; I V D Weller; D R Katz; B M Chain
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

2.  Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Alexander Kotelkin; Elena A Prikhod'ko; Jeffrey I Cohen; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 3.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

4.  Dendritic Cells Enhance HIV Infection of Memory CD4(+) T Cells in Human Lymphoid Tissues.

Authors:  Angel L Reyes-Rodriguez; Morgan A Reuter; David McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-07       Impact factor: 2.205

5.  A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells.

Authors:  I Frank; H Stössel; A Gettie; S G Turville; J W Bess; J D Lifson; I Sivin; N Romani; M Robbiani
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

6.  Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs.

Authors:  Yasuko Tsunetsugu-Yokota; Yuko Morikawa; Maya Isogai; Ai Kawana-Tachikawa; Takashi Odawara; Tetsuya Nakamura; Fernanda Grassi; Brigitte Autran; Aikichi Iwamoto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.

Authors:  Concepción Marañón; Jean-François Desoutter; Guillaume Hoeffel; William Cohen; Daniel Hanau; Anne Hosmalin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

8.  Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.

Authors:  Atsushi Yoshida; Reiko Tanaka; Tsutomu Murakami; Yoshiaki Takahashi; Yoshio Koyanagi; Masataka Nakamura; Mamoru Ito; Naoki Yamamoto; Yuetsu Tanaka
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 9.  Dendritic cell-based human immunodeficiency virus vaccine.

Authors:  C R Rinaldo
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

10.  Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.

Authors:  Ellen R Van Gulck; Guido Vanham; Leo Heyndrickx; Sandra Coppens; Katleen Vereecken; Derek Atkinson; Eric Florence; Ilse Kint; Zwi Nisan Berneman; Viggo Van Tendeloo
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.